Monica Swinney, Ph.D.

Pharmaceuticals · Biotech · Medical Devices · Drug Delivery

Monica Swinney, Ph.D.

Dr. Swinney leads drug delivery innovation and new product planning at Gilead Sciences — 22+ years in strategy and product development across medical devices, pharmaceuticals, and combination products, and an inventor on 100+ patents.

100+
Patents
17
Publications
20
Talks
22+
Years

Areas of Expertise

Deep across five connected fields

Two decades of work spanning therapeutics, devices, and sensing — with the strongest commercial impact in pharma and biotech.

Pharmaceutical

Focus

Combination products, sustained & controlled release, biologic formulations.

Biotech

Focus

Genetic medicines and novel delivery modalities, including RNA therapeutics.

Medical Devices

Innovation, concept-to-launch device development, and quality systems.

Biosensors

Continuous analyte sensing, model predictive control, and biocompatibility.

Drug Delivery

Platform development, PFSs, autoinjectors, on-body injection & infusion systems, and digital health.

Selected Work

Publications

Browse all 17

Intellectual Property

Patents

Browse all 100+

Speaking & Keynotes

On stage

20 invited talks and keynotes on drug delivery, biosensors, and innovation leadership.

See all engagements

Keynote video coming soon

PFS & Injectable Drug Devices, East Coast

Strategic Foresight in Drug Delivery Planning for Innovation, Scale, and Patient Impact

Keynote presentation.

Recognition

Honors & Awards

  • 2020

    Top 100 Innovator of 2020

    Eli Lilly and Company

  • 2014

    OSMT Award for Cross-Functional Excellence

    Becton, Dickinson and Company

  • 2011 & 2014

    SARA Award for Outstanding Contribution to a Major Project Leading to Value Creation

    Becton, Dickinson and Company

  • 2012

    Wesley J. Howe Award for Technological Innovation

    Becton, Dickinson and Company

  • 2009

    e3 Award for Excellence in Product Development

    Edwards Lifesciences